The Book Of Hor pdf R&D Daily丨Hengrui Submits Two New Indications for PD-1 for Marketing Approval Alphamab Oncology's PD-L1/CTLA-4 dual antibody KN046 received approval for Phase II clinical trial ...

wingo tool Eli Lilly's "cancer-free" RET inhibitor clinical data officially published in NEJM Well-known pharmaceutical companies respond to investigation of medical representatives Merck's SGLT-2 ...